AI Article Synopsis

Article Abstract

LC3-associated phagocytosis (LAP) is an emerging non-canonical autophagy process that bridges signaling from pattern-recognition receptors (PRRs) to autophagic machinery. LAP formation results in incorporation of lipidated LC3 into phagosomal membrane (termed LAPosome). Increasing evidence reveals that LAP functions as an innate defense mechanism against fungal pathogens. However, the molecular mechanism involved and the consequence of LAP in regulating anti-fungal immune response remain largely unexplored. Here we show that is taken into LAPosome upon phagocytosis by macrophages. Interaction of with Dectin-1 activates Syk and triggers subsequent NADPH oxidase-mediated reactive oxygen species (ROS) response that is involved in LAP induction. Inhibiting LAP induction by silencing LC3α/β or treatment with ROS inhibitor impairs the activation of MAPKs-AP-1 pathway, thereby reduces macrophage proinflammatory cytokine response to . Additionally, we unravel the importance of NLRX1 in fungus-induced LAP. NLRX1 facilitates LAP by interacting with TUFM which associates with autophagic proteins ATG5-ATG12 for LAPosome formation. Macrophages from mice or TUFM-silenced cells exhibit reduced LAP induction and LAP-mediated MAPKs-AP-1 activation for cytokine response to . Furthermore, inhibiting ROS production in macrophages almost completely abolishes -induced LC3 conversion, indicating that both Dectin-1/Syk/ROS-dependent pathway and NLRX1-TUFM complex-dependent pathway collaboratively contribute to LAP induction. Our findings reveal new pathways underlying LAP induction by for macrophage cytokine response.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286976PMC
http://dx.doi.org/10.3389/fimmu.2018.02761DOI Listing

Publication Analysis

Top Keywords

lap induction
20
cytokine response
12
lap
11
nlrx1 facilitates
8
lc3-associated phagocytosis
8
production macrophages
8
response
5
induction
5
facilitates -induced
4
-induced lc3-associated
4

Similar Publications

Article Synopsis
  • Triple-negative breast cancer (TNBC) is difficult to treat due to its aggressive characteristics, leading researchers to explore innovative delivery methods for medications.
  • Human serum albumin (HSA) was used to encapsulate Lapatinib (LAP), a drug effective against TNBC, improving its solubility and targeting capabilities in tumor environments.
  • The combination of HSA-LAP with a VEGFR-targeting peptide (VGB3) significantly enhanced anti-cancer effects, including better tumor inhibition and survival rates in animal models, indicating a compelling strategy for TNBC treatment.
View Article and Find Full Text PDF

"β-glucan signalling stimulates NOX-2 dependent autophagy and LC-3 associated autophagy (LAP) pathway".

Int J Biol Macromol

December 2024

Department of Life Sciences & Biotechnology, CSJM University, Kanpur 228024, Uttar Pradesh, India. Electronic address:

β-Glucan, a complex polysaccharide derived from fungal and yeast cell walls, plays a crucial role in modulating immune responses through their interaction with receptors such as Dectin-1 and Complement receptor 3 (CR-3). This review provides an in-depth analysis of the molecular mechanisms by which β-glucans activate receptor-mediated signalling pathways, focusing particularly on the LC3-associated phagocytosis (LAP) and autophagy pathways. Hence, we explore how β-glucan receptor engagement stimulates NADPH oxidase 2 (NOX-2), leading to the intracellular production of significant level of reactive oxygen species (ROS) essential for both conventional autophagy and LAP.

View Article and Find Full Text PDF

Triggering multiple modalities of cell death via dual-responsive nanomedicines to address the narrow therapeutic window of β-lapachone.

J Colloid Interface Sci

January 2025

Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, School of Pharmaceutical Science & Technology, Faculty of Medicine, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China. Electronic address:

The clinical translation of the anticancer drug β-lapachone (LAP) has been limited by the narrow therapeutic window. Stimuli-responsive anticancer drug delivery systems have gained tremendous attention in recent years to alleviate adverse effects and enhance therapeutic efficacy. Here, we report a dual pH- and enzyme-responsive nanocarrier to address the above issue of LAP.

View Article and Find Full Text PDF
Article Synopsis
  • Abdominoperineal resection (APR) is a surgical procedure used to treat rectal cancer, especially when it invades the levator ani muscle, but it has lower success rates compared to other rectal surgeries due to complex anatomy and high chances of local recurrence.* -
  • A robotic perineal-first approach was used in a case study of a 46-year-old man with locally advanced rectal cancer, where the surgical process involved creating an incision around the anus, dissecting tissue around the levator ani muscle, and utilizing robotic technology for greater precision.* -
  • This technique has been successfully applied to 17 patients since 2019, demonstrating its potential benefits in achieving better surgical outcomes in the challenging
View Article and Find Full Text PDF

Purpose: Although there have been many reports on learning curves for robotic surgery, it is unclear how surgeons' conventional laparoscopic surgical skills influence their ability in performing robotic surgery for colorectal cancer (CRC). The aim of this study was to determine the surgical outcomes of robotic surgery for CRC during the induction phase by skilled laparoscopic surgeons.

Methods: Surgical outcomes of consecutive CRC cases between January 2021 and March 2023 following the skilled phase of laparoscopic surgery and introductory phase of robotic surgery performed by three skilled laparoscopic surgeons were compared.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!